Article
DLAB - Deep learning methods for structure-based virtual screening of antibodies
2021-02-14
Abstract excerpt
Antibodies are one of the most important classes of pharmaceuticals, with over 80 approved molecules currently in use against a wide variety of diseases. The drug discovery process for antibody therapeutic candidates however is time-and cost-intensive and heavily reliant on in-vivo and in-vitro high throughput screens. Here, we introduce a framework for structure-based deep learning for antibodies (DLAB) which c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f4a16649-7c12-52aa-95b6-753c4b70e586
- DOI
- 10.1101/2021.02.12.430941
